WallStreetZenWallStreetZen

NASDAQ: AAPG
Ascentage Pharma Group International Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Ascentage Pharma Group International earnings were -$55.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest AAPG earnings report on Dec 31, 2024 announced Q4 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AAPG reported annual earnings of -$55.5M, with -57.5% growth.

AAPG earnings history

Current Revenue
$134.3M
Current Earnings
-$55.5M
Current Profit Margin
-41.3%

AAPG Return on Equity

Current Company
-249.8%
Current Industry
-2%
Current Market
34.1%
AAPG's Return on Equity (-1,337.4%)... subscribe to Premium to read more.
High Return on Equity Performance

AAPG undefined

Current Company
-15.9%
Current Industry
-0.4%
AAPG is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AAPG announces earnings.

AAPG undefined

Current Company
-22.94%
Current Industry
5.9%

AAPG vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AAPG-$32.47M-$55.46MN/A-$0.73
HRMY$233.41M$145.49M+148.38%$2.56
GLPG$78.56M$80.52M-16.76%$1.22
CNTA-$221.88M-$235.76MN/A-$2.06
ARQT-$109.22M-$140.04MN/A-$1.16
View Top Biotech Stocks

Ascentage Pharma Group International Earnings Reports & History FAQ

What were Ascentage Pharma Group International's earnings last quarter?

Ascentage Pharma Group International (NASDAQ: AAPG) reported Q4 2024 earnings per share (EPS) of N/A, up N/A year over year. Total AAPG earnings for the quarter were N/A. In the same quarter last year, Ascentage Pharma Group International's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Ascentage Pharma Group International stock.

Is Ascentage Pharma Group International profitable or losing money?

As of the last Ascentage Pharma Group International earnings report, Ascentage Pharma Group International is currently losing money. Ascentage Pharma Group International's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$55.54 million, a 57.46% decrease year over year.

What was AAPG's earnings growth in the past year?

As of Ascentage Pharma Group International's earnings date in Q2 2025, Ascentage Pharma Group International's earnings has grown year over year. AAPG earnings in the past year totalled -$55.46 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.